Cem Gabay
Gabay, Cem
VIAF ID: 235155042730072400676 (Personal)
Permalink: http://viaf.org/viaf/235155042730072400676
Preferred Forms
- 100 0 _ ‡a Cem Gabay
-
Works
Title | Sources |
---|---|
IL-1 receptor antagonist (IL-1Ra) does not inhibit the production of C-reactive protein or serum amyloid A protein by human primary hepatocytes : differential regulation in normal and tumour cells | |
Absence of correlation between interleukin 6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis | |
Concentrations and origins of soluble interleukin 6 receptor-α in serum and synovial fluid | |
Delayed resolution of acute inflammation during zymosan-induced arthritis in leptin-deficient mice | |
Devenir à un an d'arthrites et d'arthralgies inclassables : à propos de 32 cas et une revue de la littérature | |
Diagnostic différentiel des ténosynovites | |
Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients | |
Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency | |
Distinct roles of hepatocyte- and myeloid cell-derived IL-1 receptor antagonist during endotoxemia and sterile inflammation in mice | |
Elevated serum levels of cytokine antagonists in systemic lupus erythematosus : a likely contribution to the weak acute-phase protein response | |
Elevated serum levels of free interleukin-18 in adult-onset Still's disease. | |
Elevated serum levels of Interleukin-1 receptor antagonist in polymyositis/dermatomyositis | |
Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores? | |
Evidence-based review of biologic markers as indicators of disease progression and remission in rheumatoid arthritis | |
Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists | |
Expression and function of junctional adhesion molecule-C in human and experimental arthritis | |
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries | |
The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33. | |
Interleukin-33 biology with potential insights into human diseases | |
Interleukin-33 is biologically active independently of caspase-1 cleavage | |
Interleukin-6 and chronic inflammation | |
Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells | |
Intra-articular bioactivity of a p38 MAPK inhibitor and development of an extended-release system. | |
Investigation of Caucasian rheumatoid arthritis susceptibility loci in African patients with the same disease | |
Is IL-1 a good therapeutic target in the treatment of arthritis? | |
L'arthrose érosive des doigts | |
Leptin activates the promoter of the interleukin-1 receptor antagonist through p42/44 mitogen-activated protein kinase and a composite nuclear factor kappa B/PU.1 binding site | |
Leptin signaling deficiency impairs humoral and cellular immune responses and attenuates experimental arthritis | |
Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition. | |
Limited Contribution of IL-36 versus IL-1 and TNF Pathways in Host Response to Mycobacterial Infection | |
Magnetically retainable microparticles for drug delivery to the joint: efficacy studies in an antigen-induced arthritis model in mice | |
Mice deficient in hepatocyte-specific IL-1Ra show delayed resolution of concanavalin A-induced hepatitis. | |
Molecular characterization and subcellular localization of macrophage infectivity potentiator, a Chlamydia trachomatis lipoprotein | |
The mouse interleukin (Il)33 gene is expressed in a cell type- and stimulus-dependent manner from two alternative promoters | |
Mouse neutrophils express the decoy type 2 interleukin-1 receptor (IL-1R2) constitutively and in acute inflammatory conditions. | |
Myeloid-related proteins 8 and 14 contribute to monosodium urate monohydrate crystal-induced inflammation in gout. | |
Nanocrystal-Polymer Particles: Extended Delivery Carriers for Osteoarthritis Treatment. | |
Non-infectious lupus pericarditis: a retrospective hospital-based observation in Yaoundé-Cameroon | |
Occurrence of antiperinuclear, antikeratin, and anti-RA 33 antibodies in juvenile chronic arthritis | |
Palindromic syndrome : appearance of chondrocalcinosis after 47 years of evolution | |
The perioperative use of synthetic and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. | |
Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases--a longitudinal study | |
Polyarthrite rhumatoïde, méthotrexate et fibrose pulmonaire : quelles évidences ? | |
Polymyalgia rheumatica et artérite giganto-cellulaire : quoi de neuf ? | |
Pre-interleukin-1alpha expression reduces cell growth and increases interleukin-6 production in SaOS-2 osteosarcoma cells: Differential inhibitory effect of interleukin-1 receptor antagonist (icIL-1Ra1). | |
Presence of IL-17 in synovial fluid identifies a potential inflammatory osteoarthritic phenotype | |
Prevotella copri in individuals at risk for rheumatoid arthritis. | |
Primary human articular chondrocytes, dedifferentiated chondrocytes, and synoviocytes exhibit differential responsiveness to interleukin-4: correlation with the expression pattern of the common receptor gamma chain | |
Production of intracellular IL-1alpha, IL-1beta, and IL-1Ra isoforms by activated human dermal and synovial fibroblasts: phenotypic differences between human dermal and synovial fibroblasts | |
Prolonged treatment with Tadekinig alfa in adult-onset Still's disease | |
Recommendations for the use of ultrasound in rheumatoid arthritis: literature review and SONAR score experience | |
Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions | |
Reply to Xie et al. about the article "Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis". | |
Rheumatoid arthritis: from basic findings and clinical manifestations to future therapies. | |
Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis | |
Rituximab Retreatment in Rheumatoid Arthritis in a Real-life Cohort: Data from the CERERRA Collaboration | |
The role of female hormonal factors in the development of rheumatoid arthritis | |
The role of leptin in innate and adaptive immune responses | |
Salt-inducible kinases (SIK) inhibition reduces RANKL-induced osteoclastogenesis | |
Les sclérodermies masculines : rôle de l'exposition professionnelle | |
[Septic arthritis]. | |
Serum lipoproteins attenuate macrophage activation and Toll-Like Receptor stimulation by bacterial lipoproteins | |
The severity of experimental arthritis is independent of IL-36 receptor signaling | |
SIK inhibition in human myeloid cells modulates TLR and IL-1R signaling and induces an anti-inflammatory phenotype. | |
Soluble interleukin-6 receptor strongly increases the production of acute-phase protein by hepatoma cells but exerts minimal changes on human primary hepatocytes | |
A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated disease | |
Specific role of interleukin-1 in hepatic neutrophil recruitment after ischemia/reperfusion | |
[Spondylarthropathies in 2015]. | |
Spontaneous secretion of interleukin-17 and -22 by human cervical cells in Chlamydia trachomatis infection | |
Synovial tissues concentrate secreted APRIL. | |
La synovite villonodulaire | |
Systemic rheumatoid vasculitis: a review | |
Tocilizumab in a patient with ankylosing spondylitis and Crohn's disease refractory to TNF antagonists. | |
Tocilizumab versus adalimumab for rheumatoid arthritis - Authors' reply | |
Total hip prosthetic joint infection due to Veillonella species | |
Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab | |
Variable domain N-linked glycosylation and negative surface charge are key features of monoclonal ACPA: Implications for B-cell selection. | |
β Cell-Specific Deletion of the IL-1 Receptor Antagonist Impairs β Cell Proliferation and Insulin Secretion. |